Comparison of the EORTC QLQ-C15-PAL and the FACIT-Pal for assessment of quality of life in patients with advanced cancer

References

• Giesinger JM, Golser M, Erharter A et al. Do neurooncological patients and their significant others agree on quality of life ratings? Health Qual. Life Outcomes9(7), 87 (2009).
   Google Scholar
• Gotay CC. Assessing cancer-related quality of life across a spectrum of applications. J. Natl Cancer Inst. Monogr.33, 126–133 (2004).
   Google Scholar
• Taphoorn MJ, Claassens L, Aaronson NK et al. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Eur. J. Cancer46(6), 1033–1040 (2010).
   PubMed Web of Science ®Google Scholar
• Brady MJ, Cella DF, Mo F et al. Reliability and validity of the Functional Assessment of Cancer Therapy– Breast quality-of-life instrument. J. Clin Oncol.15(3), 974–986 (1997).
   PubMed Web of Science ®Google Scholar
• Caissie A, Culleton S, Nguyen J et al. EORTC QLQ-C15-PAL quality of life scores in patients with advanced cancer referred for palliative radiotherapy. Support Care Cancer DOI: 10.1007/s00520-011-1160-6 (2011) (Epub ahead of print).
   Google Scholar
• Zeng L, Sahgal A, Zhang L et al. Patterns of pain and functional improvement in patients with bone metastases after conventional external beam radiotherapy and a telephone validation study. Pain Res. Treat.2011, 1–9 (2011).
   Google Scholar
• Groenvold M, Petersen MA, Aaronson NK et al. The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur. J. Cancer42(1), 55–64 (2006).
   PubMed Web of Science ®Google Scholar
• Lyons KD, Bakitas M, Hegel MT et al. Reliability and validity of the functional assessment of chronic illness therapy-palliative care (FACIT-pal) scale. J. Pain Symptom Manage.37(1), 23–32 (2009).
   PubMedGoogle Scholar
• Greisinger AJ, Lorimor RJ, Aday LA et al. Terminally ill cancer patients: their most important concerns. Cancer Pract.5(3), 147–154 (1997).
   PubMedGoogle Scholar
• Rodary C, Pezet-Langevin V, Garcia-Acosta S et al. Patient preference for either the EORTC QLQ-C30 or the FACIT quality of life (QoL) measures: a study performed in patients suffering from carcinoma of an unknown primary site (CUP). Eur. J. Cancer40(4), 521–528 (2004).
   PubMed Web of Science ®Google Scholar
• Kemmler G, Holzner B, Kopp M et al. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European organization for research and treatment of cancer quality of life questionnaire-C30. J. Clin. Oncol.17(9), 2932–2940 (1999).
   PubMed Web of Science ®Google Scholar
• Greisinger AJ, Weitzner MA, Lormor RJ et al. Development of a quality of life module for end-stage cancer patients. Presented at: 1995 American Society of Clinical Oncology Annual Meeting. Los Angeles, CA, USA, 20–23 May 1995 (Abstract 1641).
   Google Scholar
• Bjorner JB, Petersen MA, Groenvold M et al. Use of item response theory to develop a shortened version of the EORTC QLQ-C30 emotional functioning scale. Qual. Life Res.13(10), 1683–1697 (2004).
   PubMed Web of Science ®Google Scholar
• Shin DW, Choi JE, Miyashita M et al. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 15-Palliative care. J. Pain Symptom Manage.41(2), 478–484 (2011).
   PubMedGoogle Scholar
• Ahlner-Elmqvist M, Bjordal K, Jordhoy MS et al. Characteristics and implications of attrition in health-related quality of life studies in palliative care. Palliat. Med.23(5), 432–440 (2009).
   PubMed Web of Science ®Google Scholar
• Holzner B, Bode RK, Hahn EA et al. Equating EORTC QLQ-C30 and FACT-G scores and its use in oncological research. Eur. J. Cancer42(18), 3169–3177 (2006).
   PubMed Web of Science ®Google Scholar
• Holzner B, Kemmler G, Sperner-Unterweger B et al. Quality of life measurement in oncology – a matter of the assessment instrument? Eur. J. Cancer37(18), 2349–2356 (2001).
   PubMed Web of Science ®Google Scholar
• Cheung YB, Goh C, Thumboo J et al. Variability and sample size requirements of quality-of-life measures: a randomized study of three major questionnaires. J. Clin. Oncol.23(22), 4936–4944 (2005).
   PubMed Web of Science ®Google Scholar
• Luckett T, King MT, Butow PN et al. Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations. Ann. Oncol. DOI: 10.1093/annonc/mdq721 (2011) (Epub ahead of print).
   PubMedGoogle Scholar
• Kopp M, Schweigkofler H, Holzner B et al. EORTC QLQ-C30 and FACT-BMT for the measurement of quality of life in bone marrow transplant recipients: a comparison. Eur. J. Haematol.65(2), 97–103 (2000).
   PubMedGoogle Scholar
• Conroy T, Mercier M, Schraub S et al. Comparison of three quality of life instruments for cancer patients: FACT-G, EORTC QLQ-C30 and FLIC. Qual. Life Res.9, 274 (2000).
   Google Scholar
• Hobday T, Sloan J, Goldberg R. Authors’ reply. J. Clin. Oncol.21, 3179 (2003).
   PubMedGoogle Scholar
• Nordin K, Steel J, Hoffman K et al. Alternative methods of interpreting quality of life data in advanced gastrointestinal cancer patients. Br. J. Cancer85(9), 1265–1272 (2001).
   PubMedGoogle Scholar
• Cheung YB, Wong LC, Tay MH et al. Order effects in the assessment of quality of life in cancer patients. Qual. Life Res.13(7), 1217–1223 (2004).
   PubMed Web of Science ®Google Scholar
• King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual. Life Res.5, 555–567 (1996).
   PubMed Web of Science ®Google Scholar
• Machin D, Campbell MJ, Fayers P et al.Sample Size Tables for Clinical Studies (3rd Edition). Blackwell, Oxford, UK (1997).
   Google Scholar
• Echteld MA, Deliens L, Onwuteaka-Philipsen B et al. EORTC QLQ-C15-PAL: the new standard in the assessment of health-related quality of life in advanced cancer? Palliat. Med.20(1), 1–2 (2006).
   PubMed Web of Science ®Google Scholar
• Groenvold M, Petersen MA, Aaronson NK et al. EORTC QLQ-C15-PAL: The new standard in the assessment of health-related quality of life in advanced cancer? Palliat. Med.20(2), 59–61 (2006).
   PubMed Web of Science ®Google Scholar
• Steinmann D, Schafer C, van Oorschot B et al. Effects of radiotherapy for brain metastases on quality of life (QoL). Prospective pilot study of the DEGRO QoL working party. Strahlenther Onkol.185(3), 190–197 (2009).
   PubMedGoogle Scholar
• Bakitas M, Lyons KD, Hegel MT et al. The project ENABLE II randomized controlled trial to improve palliative care for rural patients with advanced cancer: baseline findings, methodological challenges, and solutions. Palliat. Support. Care7(1), 75–86 (2009).
   PubMedGoogle Scholar
• Chow E, Bottomley A. Understanding the EORTC QLQ-BM22, the module for patients with bone metastases. Expert Rev. Pharmacoeconomics Outcomes Res.9(5), 461–465 (2009).
   PubMedGoogle Scholar
• Chow E, Hird A, Velikova G et al. The European Organisation for Research and Treatment of Cancer quality of life questionnaire for patients with bone metastases: the EORTC QLQ-BM22. Eur. J. Cancer45(7), 1146–1152 (2009).
   PubMed Web of Science ®Google Scholar
• Cheung YB, Goh C, Thumboo J et al. Quality of life scores differed according to mode of administration in a review of three major oncology questionnaires. J. Clin. Epidemiol.59(2), 185–191 (2006).
   PubMed Web of Science ®Google Scholar